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Purpose: We sought to determine whether Quick Sequential Organ Failure 
Assessment (qSOFA) score can be used to predict mortality of patients without 
suspected infection.  
Materials and Methods: Using prospectively collected data within the first hour of 
intensive care unit (ICU) admission, the predictive ability of qSOFA was compared to 
the Simplified-Acute-Physiology-Score (SAPS III), Admission Mortality-Prediction-
Model (MPM0 III), Acute Physiology and Chronic Health Evaluation (APACHE II) 
model, and standard (full-version) SOFA score using area under the receiver-
operating-characteristic (AUROC) curve and Brier score. 
Results: Of the 2322 patients included, 279 (12.0%) died after ICU admission. The 
qSOFA score had a modest ability to predict mortality of all critically ill patients 
(AUROC 0.672, 95% confidence interval [CI] 0.638-0.707; Brier score 0.099) 
including the non-infected patients (AUROC 0.685, 95%CI 0.637-0.732; Brier score 
0.081). The overall predictive ability and calibration of the qSOFA was comparable to 
other prognostic scores. Combining qSOFA score with lactate concentrations further 
enhanced its predictive ability (AUROC 0.730, 95%CI 0.694-0.765; Brier score 
0.097), comparable to the standard SOFA score. 
Conclusions: The qSOFA score had a modest ability to predict mortality of both 
septic and non-septic patients; combining qSOFA with plasma lactate had a predictive 
ability comparable to the standard SOFA score. 
 



















APACHE, Acute Physiology and Chronic Health Evaluation 
AUROC, area under the receiver-operating-characteristic 
ICU, intensive care unit 
qSOFA, Quick Sequential Organ Failure Assessment  
MPM, Mortality Prediction Model 
































The ability to identify patients who are at risk of subsequent deterioration and 
mortality, starting from prehospital care, emergency department to acute hospital 
ward and intensive care unit (ICU) is important [1]. Many prognostic models have 
been developed in the past three decades and each has its own strengths and 
weaknesses [2]. Some prognostic models, including the Acute Physiology and 
Chronic Health Evaluation (APACHE II-IV models), use the worst physiological 
parameters of the patients within a period of time to estimate the risk of death [3], 
while others – including the Admission Mortality Prediction Model (MPM0 III), 
Admission APACHE II and Simplified Acute Physiology Score (SAPS III) models – 
rely solely on patient characteristics on admission to the ICU to estimate the patient’s 
risk of death [4-6]. None of these scores can be considered simple and user friendly 
enough to be used in the hospital ward and emergency department settings as an early 
warning score. 
Using a composite score of different physiological parameters, many different 
medical emergency alert systems have been developed and are in use to identify 
patients who are at risk of deterioration in many healthcare institutions [7]. The ‘quick 
Sequential Organ Failure Assessment’ (qSOFA) score has recently been developed to 
facilitate early identification of patients who are at risk of mortality from suspected 
infection [8,9]. The qSOFA score uses only three physiological parameters 
(respiration rate  22 breaths/minute, altered mental state [Glasgow Coma Score <15] 
and systolic blood pressure ≤100mm Hg: total score ranges between 0 and three) and, 
despite its simplicity, it had a reasonable ability predict mortality for patients with 
sepsis both in the ICU (area under the receiver-operating-characteristic [AUROC] 















Although the standard full-version SOFA score has been shown to predict 
outcomes of both septic and non-septic critically ill patients [10-12], it is uncertain 
whether qSOFA is only useful to predict mortality of patients with suspected 
infection. In this study, we assessed the ability of ICU admission qSOFA score in 
predicting mortality in critically ill patients with and without suspected infection, 
using the physiological and biochemical data of patients obtained within the first hour 
of ICU admission. Specifically, we also compared the prognostic significance of the 
qSOFA score, either on its own or in combination with plasma lactate concentration, 
with four well-established ICU admission prognostic scores (including the SAPS III, 
Admission MPM0 III, Admission APACHE II models, and the standard full-version 
admission SOFA score)[4-6,10]. 
 
Materials and Methods 
This prospective audit study was initiated in 2008 when the study center 
started to collect physiological and biochemical data obtained within the first hour of 
ICU admission for all ICU admissions. In this study, we utilized the data of patients, 
admitted between January 1
st
 2008 and December 31
st
 2013, including those who died 
within 24 hours of ICU admission. The clinical data analyzed were de-identified, and 
as such, this study was exempt from review by the Royal Perth Hospital Ethics 
Committee and registered as a clinical audit with the Clinical Safety and Quality Unit 
(150521/02). During the study period, Royal Perth Hospital was an 800-bed 
university teaching hospital and the 22-bed ICU was a tertiary ICU that admitted 
















During the study period, all the components of the SAPS III and APACHE 
scores including both admission (obtained within the first hour of an ICU admission) 
and worst first 24-hour physiology and biochemical data were recorded for all patients 
admitted to the ICU. After the patient was discharged from ICU, the data were 
checked for transcription errors and completeness by a designated trained clerical 
staff member using data from the computerized laboratory database and going 
through the ICU vital signs flow chart again before the data were transferred to the 
computer. A single data-custodian has been responsible for ensuring data quality. The 
data were reviewed for internal consistency before annual lock-down, and there were 
no patients lost to follow-up or with missing data. ICU readmissions during same 
hospitalization were excluded from this study [3]. 
The SAPS III, MPM0III and Admission APACHE scores and predicted 
mortality were calculated as described by Moreno et al., Higgins et al., and Knaus et 
al., respectively [3-6], and were described in our previous publications [13,14]. 
Because the qSOFA score requires an assessment of a patient’s mental state, all 
patients who were intubated and received invasive mechanical ventilation within the 
first hour of ICU admission were excluded from this study, as sedation would be 
needed for such patients making the assessment of the mental state of the patients 
inaccurate. In this study, there was no missing data to generate qSOFA and the three 
ICU admission prognostic scores, but arterial lactate concentrations within the first 
hour of ICU admission were available only in 1910 patients (82.3%). 
 
Statistical analysis 
The primary outcome of interest of this study was hospital mortality. The 















within 24 hours of ICU admission and length of ICU stay >10 days. We used the 
AUROC to assess the ability of the qSOFA and other prognostic scores to 
discriminate the primary and secondary outcomes. The difference in AUROC curves 
derived from the same cases was calculated by the z statistic as described by Hanley 
and McNeil [15]. The calibration of the model was also assessed by the Hosmer-
Lemeshow chi-square statistics [16] and a calibration plot, with a p value < 0.05 
suggestive of imperfect calibration. 
We used the Brier score to assess the overall performance of the qSOFA and 
other prognostic scores [17]. This overall performance index ices will reflect both the 
discrimination and calibration of a prediction model [17]. Brier score is calculated as 
 (yi-pi)
2 
/ n, where y denotes the observed outcome while p denotes the predicted 
probability of death for subject i in the data set of n subjects. Brier scores range from 
0 to 0.25, with a Brier score of zero indicates a perfect prediction model and a Brier 
score of 0.25 signifies a useless prediction model [17].  
In addition to assessing the qSOFA score as a continuous predictor, we also 
assessed the sensitivity, specificity, positive and negative predictive values, and 
likelihood ratios of qSOFA 2 in predicting hospital mortality [9]. Because plasma 
lactate concentration was shown to have an additive prognostic effect with qSOFA 
score [9], we also analyzed the prognostic effect of a combination of plasma lactate 
concentration (grouped as <2mmol/L, 2-4mmol/L and >4mmol/L) and qSOFA. 
Finally, we also tested whether adding an interaction term between plasma lactate 
concentration and qSOFA would have any prognostic significance; if yes, it would 
suggest that plasma lactate concentration will have synergistic (rather than just 
additive) prognostic significance to the qSOFA score. In this study, a p-value <0.05 















Windows (version 22.0, IBM, USA), MedCalc for Windows (version 12.5, Ostend, 
Belgium), and S-PLUS (version 8.0, 2007; Insightful Corp., Seattle, Washington, 
USA). 
As a sensitivity analysis, we also assessed whether the qSOFA score, either 
alone or in combination with plasma lactate concentration, would be useful to predict 
mortality of all critically ill patients including those who required mechanical 
ventilation within the first hour of ICU admission (N=9458) by using the pre-
intubation Glasgow Coma Score (GCS) to estimate the qSOFA score. 
 
Results 
Characteristics of the patients 
 
Of the 9549 patients admitted to the study center during the study period, 2322 
patients (24.3%) were not intubated within the first hour of ICU admission and were 
eligible for further analysis.  Of the 2322 patients included in the study, 163 (7.0%) 
required non-invasive ventilation at the time of ICU admission, 345 patients (15%) 
required invasive mechanical ventilation within 24 hours of ICU admission, and 279 
patients (12.0%) died during the same hospital stay. Patient admission characteristics 
including age, admission source, chronic health conditions, and admission diagnosis 
were significantly different between the survivors and non-survivors (Table 1). 
 
Prognostic significance of qSOFA and other prognostic scores 
The qSOFA score had a modest ability to discriminate between survivors and 
non-survivors for all critically ill, non-intubated, patients (AUROC 0.672, 95% 
confidence interval [CI] 0.638-0.707), and also those admitted with a non-infective 















Table 2). Furthermore, the qSOFA score also had a modest ability to predict those 
who would subsequently require invasive mechanical ventilation within 24 hours of 
ICU admission (AUROC qSOFA: 0.641, 95%CI 0.596-0.686 vs. APACHE II: 0.640, 
95%CI 607-673; SAPS III: 0.608, 95%CI 0.575-0.642; MPM0III: 0.604, 95%CI 
0.570-0.638; standard SOFA: 0.632, 95%CI 0.599-0.666), and those who had a 
prolonged ICU stay longer than 10 days (AUROC 0.622, 95%CI 0.582-0.661) 
comparable to other ICU admission prognostic scores. 
As expected, the ability of the qSOFA score to discriminate between survivors 
and non-survivors was slightly inferior to those of the SAPS III, MPM0 III, APACHE 
II models, and the standard (full-version) admission SOFA score (all p<0.001), but 
the qSOFA’s overall predictive ability, as measured by the Brier scores (Brier score: 
0.099), was not too different from those of the SAPS III (Brier score: 0.089), MPM0 
III (Brier score: 0.096), Admission APACHE II models (Brier score: 0.096), and 
admission SOFA score (Brier score: 0.105). Restricting our analyses to patients with 
septic shock or sepsis alone produced similar results (Table 2). In terms of 
calibration, the qSOFA also appeared to be reasonably well calibrated (Table 2) 
compared to other prognostic scores, and had a relatively linear relationship with the 
observed mortality (Figure 2).  
 
Using qSOFA 2 as a warning sign and combining qSOFA with plasma lactate 
concentration 
Using a qSOFA 2 on admission to ICU as a cut-point [9] , the sensitivity, 
specificity, positive predictive value, negative predictive value, positive and negative 















(95%CI 0.80-0.83), 24.8% (95%CI 21.2-28.7), 91.6% (90.3-92.8), 2.4 (95%CI 2.1-
2.8) and 0.7 (95%CI 0.6-0.8), respectively.  
When the qSOFA was combined with arterial lactate concentrations (grouped 
in three categories), its ability to predict hospital mortality was further enhanced 
(AUROC 0.730, 95%CI 0.694-0.765; Brier score 0.097) (Figure 3 and Table 2) and 
became comparable to the standard (full-version) admission SOFA (AUROC 0.727, 
95%CI 0.695-0.759; Brier score 0.105). The odds ratio (OR) for mortality per 
increment of qSOFA was 2.0 (95%CI 1.7-2.4), and ORs for lactate: 2-4mmol/L and 
lactate>4mmol/L were 1.7 (95%CI 1.2-2.4) and 4.1 (2.9-6.0), respectively, compared 
to patients with lactate <2mmol/L. An interaction term between lactate and qSOFA 
was not significant (p=0.685) in predicting mortality, suggesting that qSOFA score 




 Using pre-intubation GCS to estimate the ICU admission qSOFA scores, its 
ability to discriminate between hospital survivors and non-survivors for all ICU 
admissions (AUROC 0.663, 95%CI 0.648-0.679) remained similar to restricting the 
analysis only to those not requiring mechanical ventilation within the first hour of 
ICU admission (AUROC 0.672, 95%CI 0.638-0.707). Combining admission lactate 
concentration with qSOFA score further improved their overall ability to discriminate 
between hospital survivors and non-survivors regardless of whether they were 
mechanically ventilated on ICU admission (AUROC 0.734, 95%CI 0.718-0.751), 
almost comparable to predictive ability of the standard admission SOFA score 

















This study showed that the qSOFA score within the first hour of ICU 
admission had a modest ability to differentiate between survivors and non-survivors 
for both septic and non-septic critically ill, non-intubated, patients, comparable to 
some well-established ICU admission prognostic scores. Combining qSOFA with 
lactate concentration further enhanced its ability to predict mortality of critically ill 
patients, comparable to the standard (full-version) admission SOFA score. In addition, 
the qSOFA score also had a modest ability to predict the risk of requiring invasive 
mechanical ventilation within 24 hours of ICU admission and prolonged ICU stay 
when applied to both septic and non-septic patients who were not ventilated on 
admission to the ICU.  These results are clinically relevant and require further 
discussion. 
First, our results confirmed that the qSOFA score had a modest ability to 
discriminate between survivors and non-survivors (AUROC 0.67) when applied to all 
critically ill non-intubated patients, very similar to the results reported in the qSOFA 
validation study when only septic ICU patients were included (AUROC 0.66)[9]. 
Because qSOFA score is easy and simple to use, it has a huge potential to be 
incorporated as an early warning tool for hospitalized patients, beyond identifying 
septic patients who are at risk of subsequent mortality [9]. Using a qSOFA score 2 as 
a sole criterion, it had a high negative predictive value and a low negative likelihood 
ratio, suggesting that a qSOFA <2 would be useful to ‘rule out’ hospitalized patients 
who are at high risk of subsequent deterioration and mortality. Our results also 
confirmed the additive (but not synergistic) prognostic significance of plasma lactate 















combined predictive ability became almost comparable to the standard (full-version) 
SOFA score (Table 2). For instance, when combined with plasma lactate 
concentrations >4mmol/L, a qSOFA score of 2 and 3 were associated with a 
substantial risk of subsequent mortality (at 35% and 55% respectively) compared to 
<5% mortality for patients with a qSOFA of zero and normal lactate concentration 
(<2mmol/L)(Figure 3). Even a moderate increase in lactate concentration (between 2 
and 4mmol/L) would substantially increase the risk of mortality for patients with a 
qSOFA 2 (mortality 25% and 42% for qSOFA scores 2 and 3 respectively). As such, 
when combined with an elevated lactate concentration (>2mmol/L), a qSOFA2 
would be very useful to ‘rule a patient in’ as a high-risk patient who is likely to 
deteriorate resulting in subsequent mortality. Taken together with the data from the 
recent large qSOFA validation study [8,9], our results strongly support the utility of 
qSOFA in combination with plasma lactate concentration as a simple, and yet 
reasonably sensitive, tool to identify both infected and non-infected hospitalized 
patients who are at risk of subsequent deterioration and mortality. Because qSOFA 
with lactate concentration is much easier to use than the standard SOFA score, 
qSOFA with lactate concentration may be particularly applicable in the hospital ward, 
emergency department, and pre-hospital settings where a quick assessment is needed 
to stratify patients’ risk of subsequent deterioration [18]. 
Second, although qSOFA score had a modest ability to discriminate between 
survivors and non-survivors, it can, by no means, possible to replace other well-
established ICU prognostic scores for quality assurance and research purposes. This is 
because qSOFA score would not be accurate once sedation is used. In addition, its 
overall discrimination ability is still not as good as the SAPS III, MPM0 III or 















Third, we would like to acknowledge the limitations of this study. Although 
we had included a reasonable number of patients, this was still a single center study 
and our results may not be applicable to centers with very different case-mix [19]. 
Because the coefficients of the qSOFA mortality prediction equation were not 
available in the public domain, we could not compare the slope and intercept of the 
calibration curve of the qSOFA score with those from other ICU admission prognostic 
scores in this study. Finally, our study was underpowered to assess the difference in 
performance of the qSOFA score in patients with different admission diagnoses [3-6], 
and this merits further investigation by a multicenter study. 
In conclusion, qSOFA score had a modest ability to predict requirement for 
invasive mechanical ventilation, prolonged ICU stay, and mortality of septic and non-
septic critically ill patients. Its ability to predict mortality was further enhanced when 
combined with lactate concentration, resulting in a predictive ability comparable to 
the full-version SOFA score. Combining qSOFA score with plasma lactate 
concentration represents a simple, and yet reasonably sensitive, tool to identify both 
septic and non-septic patients who are risk of subsequent deterioration and mortality. 
Use of qSOFA with plasma lactate concentration as an early warning tool for 
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Figure 1. Areas under the receiver-operating-characteristic (AUROC) of quick 
Sequential Organ Failure Assessment (qSOFA) score and other intensive care 
prognostic scores. APACHE, Acute Physiology and Chronic Health Evaluation. 
SAPS, Simplified Acute Physiology Score. MPM0, Admission Mortality Prediction 
Model. 
 
Figure 2. Relationship between quick Sequential Organ Failure Assessment (qSOFA) 
score of non-intubated critically ill patients within the first hour of intensive care unit 
admission and the risk of subsequent hospital mortality. 
 
Figure 3. Association between the quick Sequential Organ Failure Assessment 
(qSOFA) score of non-intubated critically ill patients within the first hour of intensive 
care unit admission and risk of subsequent hospital mortality, stratified by 



































































Table 1. Characteristics of the study cohort (N=2322). 
 
Variable   Total cohort Survivors Non-survivors P value
#
 
     (N=2322) (n=2043) (n=279, 12.0%) 
 
Age, years (IQR)   57.1 (41-70) 55.9 (39-69) 60.1 (54-78) 0.001 
Male, no. (%)    1423 (61) 1245 (61) 178 (64)  0.394 
ICU Admission source, no. (%)       0.001 
- Operating theatre  676 (29)  647 (32)  29 (10) 
- Emergency Department 663 (29)  595 (29)  68 (24) 
- Ward   689 (30)  546 (27)  143 (52) 
- CCU/HDU  108 (5)  87 (4)  21 (8) 
- Other hospital  165 (7)  149 (7)  16 (6) 
- Other hospital ICU  21 (1)  19 (1)  2 (0.7) 
Elective surgery, no. (%)  453 (19.5) 433 (21)  20 (7)  0.001 
Ward stay before ICU, days (IQR) 4 (2-11)  4 (1-10)  5 (2-15)  0.003 
Admission APACHE II score (IQR) 12.0 (8-18) 11.0 (7-17) 20 (15-24) 0.001 
Worst 24-hr APACHE II score (IQR) 17.0 (12-23) 16 (11-21) 26 (19-30) 0.001 
SAPS III score (IQR)  41 (32-50) 39 (30-48) 54 (46-62) 0.001 
SAPS III predicted risk, % (IQR) 6.3 (2-16) 4.9 (1-13) 22.0 (11-37) 0.001 
MPM0 III predicted risk, % (IQR) 9.4 (4-18) 8.5 (4-16 ) 19.2 (11-31) 0.001 
Adm. qSOFA score, (IQR) 1 (0-1) 0 (0-1)  1 (1-2)  0.001 
Adm. qSOFA predicted risk, % (IQR) 11.2 (6-11) 11.2 (6-11) 11.2 (11-22) 0.001 
Adm. SOFA score, (IQR)  4 (2-6)  4 (2-6)  6 (4-8)  0.001 
Adm. SOFA predicted risk, % (IQR) 10.2 (6-17) 10.2 (6-17) 17.4 (10-28) 0.001  
ICU stay, days (IQR)  3 (2-5)  3 (2-5)  4 (2-8)  0.001 
Hospital stay, days (IQR)  14 (7-28)  14 (8-28)  13 (4-28)  0.007 
Chronic medical conditions (%):*    
- Respiratory  132 (6)  107 (5)  25 (9)  0.018 
- Cardiovascular  196 (8)  156 (8)  40 (14)  0.001 
- Liver    92 (4)  72 (4)  20 (7)  0.008 
- Renal   227 (10)  185 (9)  42 (15)  0.003 
- Immune disease  48 (2)  35 (2)  13 (5)  0.005  
- Immune treatment  166 (7)  129 (6)  37 13)  0.001 
- Metastatic cancer  30 (1)  27 (1)  3 (1)  0.999 
- Lymphoma  22 (1)  11 (0.5)  11 (4)  0.001 
- Leukaemia / myeloma 75 (3)  58 (3)  17 (6)  0.010 
- AIDS   5 (0.2)  2 (0.1)  3 (1)  0.014 
Major admission diagnoses, no. (%): 
Cardiac or respiratory arrest  8 (0.3)  7 (0.3)  1 (0.4)  0.999 
Pneumonia    186 (8)  159 (8)  27 (10)  0.289  
Septic shock    422 (18)  326 (16)  96 (34)  0.001 
Multiple trauma   142 (6)  133 (7)  9 (3)  0.032 
Isolated head trauma  33 (1)  32 (2)  1 (0.4)  0.171 
Intracranial haemorrhage  37 (2)  31 (2)  6 (2)  0.440 
Drug overdoses   41 (2)  40 (2)  1 (0.4)  0.053 
Congestive heart failure,  107 (5)  78 (4)  29 (10)  0.001 
ischaemic heart disease, or 
cardiogenic shock 
Peripheral vascular disease or  97 (4)  93 (5)  4 (1)  0.010 
aortic aneurysm 
GI obstruction or perforation  24 (1)  24 (1)  0 (0)  0.105 
Aspiration pneumonia  32 (1)  30 (2)  2 (0.7)  0.419  
Obstructive airway disease  73 (3)  69 (3)  4 (1)  0.098 
Acute lung injury or ARDS  25 (1)  21 (1)  4 (1)  0.532 
Gastrointestinal bleeding  56 (2)  50 (2)  6 (2)  0.999 
Pulmonary embolism  18 (0.8)  15 (0.7)  3 (1)  0.469 
 
 
All values are median and interquartile range (IQR) in parenthesis unless stated otherwise. GI, Gastrointestinal. 
APACHE, Acute Physiology and Chronic Health Evaluation. ARDS, Acute Respiratory Distress Syndrome. CCU, 
Coronary Care Unit. HDU, High Dependency Unit. ICU, intensive care unit. MPM0, Mortality Prediction Model 
on admission. qSOFA, Quick Sequential Organ Failure Assessment. SAPS, Simplified Acute Physiology Score. 
*According to the definitions by the APACHE model. # P values generated by either Mann-Whitney or Chi-square 
















Table 2. Performance of the admission Quick Sequential Organ Failure Assessment (qSOFA), 
Mortality Prediction Model on admission (MPM0 III), Simplified Acute Physiology Score (SAPS III), 
and admission and worst first 24-hr Acute Physiology and Chronic Health Evaluation (APACHE II) 
predicted risks in predicting mortality of critically ill patients who did not require an endotracheal tube 
on admission to the intensive care unit. AUROC, area under the receiver-operating-characteristic curve. 
CI, Confidence Interval. 
 
All patients (N=2322)  AUROC  Hosmer-Lemeshow 
2 
Brier Score 
    (95%CI)  (p value)   
qSOFA    0.672 (0.638-0.707) 2.7 (0.103)  0.099 
Combining qSOFA with lactate
#
 0.730 (0.694-0.765) 1.0 (0.966)  0.097 
SOFA    0.727 (0.695-0.759) 8.7 (0.273)  0.105 
MPM0 III    0.749 (0.719-0.779) 23.0 (0.003)  0.096 
SAPS III   0.806 (0.781-0.831) 35.0 (0.001)  0.089 
APACHE II (admission)  0.793 (0.766-0.820) 24.6 (0.002)  0.096 
APACHE II (worst first 24-hr) 0.803 (0.777-0.829) 15.5 (0.050)  0.119 
 
 
Non-infective diagnosis (n=1658) AUROC  Hosmer-Lemeshow 
2
 Brier Score 
    (95%CI)  (p value)   
qSOFA    0.685 (0.637-0.732) 0.1 (0.865)  0.081 
Combining qSOFA with lactate
#
 0.728 (0.682-0.774) 2.1 (0.733)  0.080 
SOFA    0.733 (0.692-0.774) 8.2 (0.226)  0.087 
MPM0 III    0.757 (0.715-0.800) 25.8 (0.001)  0.078 
SAPS III   0.819 (0.784-0.854) 24.4 (0.002)  0.071 
APACHE II (admission)  0.814 (0.776-0.851) 20.7 (0.008)  0.076 
APACHE II (worst first 24-hr) 0.829 (0.794-0.864) 15.9 (0.044)  0.090 
 
Septic shock* (n=422)  AUROC  Hosmer-Lemeshow 
2
 Brier Score 
    (95%CI)  (p value)   
qSOFA    0.637 (0.573-0.701) 3.7 (0.157)  0.174 
Combining qSOFA with lactate
#
 0.701 (0.630-0.771) 4.6 (0.602)  0.158 
SOFA    0.684 (0.619-0.749) 3.5 (0.835)  0.163 
MPM0 III    0.708 (0.650-0.766) 7.1 (0.531)  0.162 
SAPS III   0.723 (0.665-0.780) 5.0 (0.754)  0.155 
APACHE II (admission)  0.717 (0.659-0.775) 3.8 (0.874)  0.167 
APACHE II (worst first 24-hr) 0.726 (0.666-0.787) 8.5 (0.387)  0.212 
 
 
Sepsis** (n=242)  AUROC  Hosmer-Lemeshow 
2
 Brier Score 
    (95%CI)  (p value)   
qSOFA    0.600 (0.483-0.717) 0.1 (0.866)  0.101 
Combining qSOFA with lactate
#
 0.654 (0.523-0.785) 4.2 (0.241)  0.099 
SOFA    0.619 (0.505-0.733) 8.5 (0.207)  0.111 
MPM0 III    0.657 (0.543-0.771) 7.6 (0.473)  0.103 
SAPS III   0.692 (0.593-0.791) 6.8 (0.455)  0.102 
APACHE II (admission)  0.732 (0.632-0.832) 9.6 (0.293)  0.110 
APACHE II (worst first 24-hr) 0.702 (0.598-0.806) 10.8 (0.211)  0.156 
 
# 
Plasma lactate grouped into three categories: <2mmol/L, 2-4mmol/L and >4mmol/L. * Septic shock 
was defined as sepsis with cardiovascular failure requiring inotropic support as per APACHE II 
definition. ** Including patients with pneumonia, aspiration and bowel perforation. The odds ratio 
(OR) for mortality per increment of qSOFA was 2.0 (95%CI 1.7-2.4), and ORs for lactate: 2-4mmol/L 
and lactate>4mmol/L were 1.7 (95%CI 1.2-2.4) and 4.1 (2.9-6.0), respectively. An interaction term 
between lactate and qSOFA was not significant (p=0.685) in predicting mortality, suggesting that 


















 Quick Sequential Organ Failure Assessment (qSOFA) score has been shown 
to predict the risk of mortality in patients with suspected infection.  
 
 This study extended the utility of qSOFA, and showed that it also had a 
modest ability to predict the requirement of invasive mechanical ventilation, 
prolonged ICU stay, and mortality in all critically ill patients, including those 
with a non-infective diagnosis.  
 
 The qSOFA’s ability to predict mortality was further enhanced when 
combined with lactate concentration.  
 
 Combining qSOFA score with plasma lactate concentration represents a 
simple, and yet reasonably sensitive, tool to identify both septic and non-septic 
patients who are risk of subsequent deterioration and mortality. 
